<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: New Treatment for Prostate Cancer?; Red Meat, Fiber &amp; Colon Cancer; Malpractice &amp; Errors in Surgery</title>
	<atom:link href="http://mensnewsdaily.com/2007/11/18/new-treatment-for-prostate-cancer-red-meat-fiber-colon-cancer-malpractice-errors-in-surgery/feed/" rel="self" type="application/rss+xml" />
	<link>http://mensnewsdaily.com/2007/11/18/new-treatment-for-prostate-cancer-red-meat-fiber-colon-cancer-malpractice-errors-in-surgery/</link>
	<description>Men&#039;s Rights Activism, MRA Politics, Analysis, Commentary and Global News</description>
	<lastBuildDate>Sun, 08 Nov 2009 09:00:02 -1000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Robert A. Wascher, MD, FACS</title>
		<link>http://mensnewsdaily.com/2007/11/18/new-treatment-for-prostate-cancer-red-meat-fiber-colon-cancer-malpractice-errors-in-surgery/comment-page-1/#comment-54856</link>
		<dc:creator>Robert A. Wascher, MD, FACS</dc:creator>
		<pubDate>Mon, 19 Nov 2007 01:16:11 +0000</pubDate>
		<guid isPermaLink="false">http://mensnewsdaily.com/2007/11/18/new-treatment-for-prostate-cancer-red-meat-fiber-colon-cancer-malpractice-errors-in-surgery/#comment-54856</guid>
		<description>RE &quot;mark123&quot; comment (&quot;The Doctor has NOT done his due diligence... the procedure has been approved and is in commercial use just about everywhere in the world but the U.S.&quot;):

Indeed... however I cannot recommend that patients undergo novel, &quot;non-standard-of-care&quot; cancer treatments in this country outside of participation in prospective, randomized clinical trials as I indicated in my review of the Journal of Urology paper, and as &quot;mark123&quot; has referenced via the National Institutes of Health (NIH) clinical trials website (nor, unfortunately, can I ethically issue recommendations to the general public to enroll in specific clinical research trials).  

To reiterate: in my view, mature follow-up data from larger scale prospective clinical research trials will be necessary before most U.S. prostate cancer experts will be able to recommend HIFU as a therapy equivalent to the current standard-of-care prostate cancer treatments.  Until such long-term data is available, U.S. patients interested in HIFU as a potential treatment for prostate cancer therapy should, in my opinion, consider participating in NIH-funded prospective clinical trials, such as this reader has mentioned.

Robert A. Wascher, MD, FACS</description>
		<content:encoded><![CDATA[<p>RE &#8220;mark123&#8243; comment (&#8221;The Doctor has NOT done his due diligence&#8230; the procedure has been approved and is in commercial use just about everywhere in the world but the U.S.&#8221;):</p>
<p>Indeed&#8230; however I cannot recommend that patients undergo novel, &#8220;non-standard-of-care&#8221; cancer treatments in this country outside of participation in prospective, randomized clinical trials as I indicated in my review of the Journal of Urology paper, and as &#8220;mark123&#8243; has referenced via the National Institutes of Health (NIH) clinical trials website (nor, unfortunately, can I ethically issue recommendations to the general public to enroll in specific clinical research trials).  </p>
<p>To reiterate: in my view, mature follow-up data from larger scale prospective clinical research trials will be necessary before most U.S. prostate cancer experts will be able to recommend HIFU as a therapy equivalent to the current standard-of-care prostate cancer treatments.  Until such long-term data is available, U.S. patients interested in HIFU as a potential treatment for prostate cancer therapy should, in my opinion, consider participating in NIH-funded prospective clinical trials, such as this reader has mentioned.</p>
<p>Robert A. Wascher, MD, FACS</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: mark123</title>
		<link>http://mensnewsdaily.com/2007/11/18/new-treatment-for-prostate-cancer-red-meat-fiber-colon-cancer-malpractice-errors-in-surgery/comment-page-1/#comment-54840</link>
		<dc:creator>mark123</dc:creator>
		<pubDate>Sun, 18 Nov 2007 20:22:40 +0000</pubDate>
		<guid isPermaLink="false">http://mensnewsdaily.com/2007/11/18/new-treatment-for-prostate-cancer-red-meat-fiber-colon-cancer-malpractice-errors-in-surgery/#comment-54840</guid>
		<description>The Doctor has NOT done his due diligence.  Currently, Phase 2/3 trials are underway using HIFU headed by a Urologist from Georgetown Medical Center.  Additionally, the procedure has been approved and is in commercial use just about everywhere in the world but the U.S.  One company based in France has completed over 13,000 procedures over a 10 year period with results dramatically higher than stated in this article.  For men seeking additional information about the procedure, go to www.clinicaltrials.gov and type in the term ablatherm, which is the name of the robotic machine used in the trials.</description>
		<content:encoded><![CDATA[<p>The Doctor has NOT done his due diligence.  Currently, Phase 2/3 trials are underway using HIFU headed by a Urologist from Georgetown Medical Center.  Additionally, the procedure has been approved and is in commercial use just about everywhere in the world but the U.S.  One company based in France has completed over 13,000 procedures over a 10 year period with results dramatically higher than stated in this article.  For men seeking additional information about the procedure, go to <a href="http://www.clinicaltrials.gov" rel="nofollow">http://www.clinicaltrials.gov</a> and type in the term ablatherm, which is the name of the robotic machine used in the trials.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
